Spondylodiscitis associated with recurrent Serratia bacteremia due to a transjugular intrahepatic portosystemic shunt (TIPS): a case report.
We report a case of spondylodiscitis caused by multiresistant Serratia marcescens in a cirrhotic patient who had several Serratia bacteremias after the placement of a transjugular intrahepatic portosystemic shunt (TIPS) device. We concluded that an endovascular stent that can not be removed makes management of recurrent bacteremia difficult. Furthermore, back pain due to bacteremia is indicative of spondylodiscitis. Serratia marcescens can be an aggressive pathogen, causing spinal infection.
Marques
Nuno
N
Infectious Diseases Department, University of Coimbra, Praceta Prof. Mota Pinto, Coimbra, Portugal.
Sá
Rosa
R
Coelho
Filomena
F
da Cunha
Saraiva
S
Meliço-Silvestre
A
A
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D015299:Discitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D019168:Portasystemic Shunt, Transjugular Intrahepatic / Q000009:adverse effects*; D016868:Serratia Infections / Q000175:diagnosis* / Q000188:drug therapy; D012706:Serratia marcescens / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D015378:Imipenem